Effect of cortistatin on tau phosphorylation at Ser262 site

Journal of Neuroscience Research

Volumn 86, Issue 11, 2008, Pages 2462-2475

  Rubio, Alicia ^a   Pérez, Mar ^a   de Lecea, Luis ^b   Ávila, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Internalization; Real time PCR; Somatostatin; Somatostatin receptors

Indexed keywords

CORTISTATIN; PROTEIN KINASE C; SERINE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 4; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; BRAIN CORTEX; BRAIN REGION; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPEPTIDES; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAU PROTEINS; TRANSFECTION;

EID: 49349088002     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21689     Document Type: Article

References (65)

1. Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K. 2003. Molecular mechanisms and therapeutical implications of intramembrane receptor/ receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509-550.
2. Allia E, Tarabra E, Volante M, Cerrato M, Ghigo E, Muccioli G, Papotti M. 2005. Expression of cortistatin and MrgX2, a specific cortistatin receptor, in human neuroendocrine tissues and related turnouts. J Pathol 207:336-345.
3. Alzheimer A. 1906. Neurologisches Zentralblatt 25:146-148.
4. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. 1992. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42:631-639.
5. Avila J, Lucas JJ, Perez M, Hernandez F. 2004. Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361-384.
6. Banker GA, Cowan WM. 1977. Rat hippocampal neurons in dispersed cell culture. Brain Res 126:397-342.
7. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K. 2001. Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Set 262/356. FEBS Lett 490:15-22.
8. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and micrombule binding. Neuron 11:153-163.
9. Bissette G, Cook L, Smith W, Dole KC, Crain B, Nemeroff CB. 1998. Regional neuropeptide pathology in Alzheimer's disease: corticotropin-releasing factor and somatostatin. J Alzheimers Dis 1:91-105.
10. Boudin H, Satter P, Mazella J, Schonbrunn A, Beaudet A. 2000. Somatostatin-induced regulation of SST(2A) receptor expression and cell-surface availability in central neurons: role of receptor internalization. J Neurosci 20:5932-5939.
11. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
12. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
13. Buscigho J, Lorenzo A, Yeh J, Yankner BA. 1995. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888.
14. Correas I, Diaz-Nido J, Avila J. 1992. Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. J Biol Chem 267:15721-15728.
15. Criado JR, Li H, Jiang X, Spina M, Huitron-Resendiz S, Liapakis G, Calbet M, Siehler S, Henriksen SJ, Koob G, Hoyer D, Sutcliffe JG, Goodman M, de Lecea L. 1999. Structural and compositional determinants of cortistatin activity. J Neurosci Res 56:611-619.
16. Cristiani R, Fontanesi G, Casini G, Petrucci C, Viollet C, Bagnoli P. 2000. Expression of somatostatin subtype 1 receptor in the rabbit retina. Invest Ophthalmol Vis Sci 41:3191-3199.
17. Csaba Z, Dournaud P. 2001. Cellular biology of somatostatin receptors. Neuropeptides 35:1-23.
18. Davies P, Katzman R, Terry RD. 1980. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia. Nature 288:279-280.
19. de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR, Henriksen Sj, Sutcliffe JG. 1996. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242-245.
20. de Lecea L, del Rio JA, Criado JR, Alcantara S, Morales M, Danielson PE, Henriksen SJ, Soriano E, Sutcliffe JG. 1997. Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci 17:5868-5880.
21. Deghenghi R, Papotti M, Ghigo E, Muccioli G. 2001. Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J Endocrinol Invest 24:RC1-RC3.
22. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. 1999. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52:1158-1165.
23. Diaz-Nido J, Serrano L, Lopez-Otin C, Vandekerckhove J, Avila J. 1990. Phosphorylation of a neuronal-specific beta-tubulin isotype. J Biol Chem 265:13949-13954.
24. Drewes G, Elmeth A, Preuss U, Mandelkow EM, Mandelkow E. 1997. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell 89:297-308.
25. Feindt J, Becker I, Blomer U, Hugo HH, Mehdom HM, Krisch B, Mentlein R. 1995. Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J Neurochem 65:1997-2005.
26. Flood JF, Uezu K, Morley JE. 1997. The cortical neuropeptide, cortistatin-14, impairs post-training memory processing. Brain Res 775:250-252.
27. Fukusumi S, Kitada C, Takekawa S, Kizawa H, Sakamoto J, Miyamoto M, Hinuma S, Kitano K, Fujino M. 1997. Identification and characterization of a novel human cortistatin-like peptide. Biochern Biophys Res Commun 232:157-163.
28. Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. 1989. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393-399.
29. Goedert M, Cohen ES, Jakes R, Cohen P. 1992. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS Lett 312:95-99.
30. Gomez-Ramos A, Diaz-Nido J, Smith MA, Perry G, Avila J. 2003. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J Neurosci Res 71:863-870.
31. Greenberg SG, Davies P, Schein JD, Binder LI. 1992. Hydrofluoric acidtreated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem 267:564-569.
32. Heidet V, Faivre-Bauman A, Kordon C, Loudes C, Rasolonjanahary S, Epelbaum J. 1990. Functional maturation of somatostatin neurons and somatostatin receptors during development of mouse hypothalamus in vivo and in vitro. Brain Res Dev Brain Res 57:85-92.
33. Hofland LJ, Lamberts SW. 2003. The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocrine Rev 24:28-47.
34. Hosli E, Hosli L. 1994. Colocalization of binding sites for somatostatin, muscarine and nicotine on cultured neurones of rat neocortex, cerebellum, brain stem and spinal cord: combined autoradiographic and immunohistochemical studies. Neurosci Lett 173:71-74.
35. Hukovic N, Panetta R, Kumar U, Patel YC. 1996. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137:4046-4049.
36. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease; cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
37. Iqbal K, Grundke-Iqbal 1. 1997. Mechanism of Alzheimer neurofibrillary degeneration and the formation of tangles. Mol Psychiatry 2:178-180.
38. Kumar U. 2005. Expression of somatostatin receptor subtypes (SSTR15) in Alzheimer's disease brain: an immunohistochemical analysis. Neuroscience 134:525-538.
39. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A. 2005. Receptor signaling and endocytosis are differentially regulated by somarostatin analogs. Mol Pharmacol 68:90-101.
40. Mentlein R, Buchholz C, Krisch B. 1990. Somatostatin-binding sites on rat telencephalic astrocytes. Light- and electron-microscopic studies in vitro and in vivo. Cell Tissue Res 262:431-443.
41. Moller LN, Stidsen CE, Hartmann B, Holst JJ. 2003. Somatostatin receptors. Biochim Biophys Acta 1616:1-84.
42. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y. 1995. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 270:823-829.
43. Nilsson CL, Brinkmalm A, Minthon L, Blennow K, Ekman R. 2001. Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Peptides 22:2105-2112.
44. Novak M, Jakes R, Edwards PC, Milstein C, Wischik CM. 1991. Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51. Proc Natl Acad Sci U S A 88:5837-5841.
45. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. 1994. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669-673.
46. Parameswaran N, Spielman WS. 2006. RAMPs: the past, present and future. Trends Biochem Sci (in press).
47. Paudel HK. 1997. The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase. J Biol Chem 272:1777-1785.
48. Perez M, Bibe E, Rubio A, Lim F, Moran MA, Ramos PG, Ferrer I, Isla MT, Avila J. 2005. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130:339-347.
49. Rahman A, Grundke-Iqbal I, Iqbal K. 2006. PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau. J Neural Transm. 113:219-230.
50. +ATP channel in insulin-secreting mammalian HIT and RIN cell lines. J Physiol 485:73-86.
51. Robas N, Mead E, Fidock M. 2003. MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 278:44400-44404.
52. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, Suemoto T, Higuchi M, Saido TC. 2005. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med 11:434-439.
53. Sanchez-Alavez M, Gomez-Chavarin M, Navarro L, Jimenez-Anguiano A, Murillo-Rodriguez E, Prado-Alcala RA, Drucker-Colin R, Prospero-Garcia O. 2000. Cortistatin modulates memory processes in rats. Brain Res 858:78-83.
54. Scott CW, Spreen RC, Herman JL, Chow FP, Davison MD, Young J, Caputo CB. 1993. Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J Biol Chem 268:1166-1173.
55. Schindler M, Humphrey PP, Emson PC. 1996. Somarostatin receptors in the central nervous system. Prog Neurobiol 50:9-47.
56. Schreff M, Schulz S, Handel M, Keilhoff G, Braun H, Pereira G, Klutzny M, Schmidt H, Wolf G, Hollt V. 2000. Distribution, targeting, and internalization of the sst4 somarostatin receptor in rat brain. J Neurosci 20:3785-3797.
57. Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg I, Trojanowski JQ, et al. 1995. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem 270:18917-18922.
58. 125I]Tyr10-cortistatin14 labels all five somatostatin receptors. Naunyn Schimedebergs Arch Pharmacol 357:483-489.
59. Singh TJ, Grundke-Iqbal I, McDonald B, Iqbal K. 1994. Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases. Mol Cell Biochem 131:181-189.
60. Stroh T, Jackson AC, Dal Farra C, Schonbrunn A, Vincent JP, Beaudet A. 2000. Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons. Synapse 38:177-186.
61. Tallent MK, Fabre V, Qiu C, Calbet M, Lamp T, Baratta MV, Suzuki C, Levy CL, Siggins GR, Henriksen SJ, Criado JR, Roberts A, de Lecea L. 2005. Cortistatin overexpression in transgenic mice produces deficits in synaptic plasticity and learning. Mol Cell Neurosci 30: 465-475.
62. van Calker D, Muller M, Hamprecht B. 1980. Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells. Proc Natl Acad Sci U S A 77:6907-6911.
63. 125I]Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain. Naunyn Schmiedebergs Arch Pharmacol 367:562-571.
64. Winsky-Sommerer R, Spier AD, Fabre V, de Lecea L, Criado JR. 2004. Overexpression of the human beta-amyloid precursor protein downregulates cortistatin mRNA in PDAPP mice. Brain Res 1023:157-162.
65. Xiao-Chuan W, Zheng-Hui H, Zheng-Yu F, Yue F, Yun-Huang Y, Qun W, Xiao-Wei T, Yi-Gen W, Jian-Zhi W. 2004. Correlation of Alzheimer-like tau hyperphosphorylation and fMRI bold intensity. Curr Alzheimer Res 1:143-148.